Şunu aradınız:: polymyxin (İngilizce - Maltaca)

infanrix hexa contains neomycin and polymyxin
infanrix hexa fih neomycin u polymyxin

formaldehyde neomycin or polymyxin (antibiotics).
formalina neomycin jew polymyxin (antibijotiċi).

this vaccine contains neomycin and polymyxin (antibiotics).
dan il-vaċċin fih neomycin u polymyxin (antibijotiċi).

cross resistance between colistimethate sodium and polymyxin b is expected.
reżistenza inkroċjata bejn colistimethate sodium u polymyxin b hija mistenni.

colobreathe contains colistimethate sodium, a type of antibiotic called a polymyxin.
colobreathe fih colistimethate sodium li huwa tip t’antibijotiku msejjaħ polymyxin.

hypersensitivity to the active substances or to any of the excipients or neomycin and polymyxin.
sensittivita' eċċessiva għas-sustanzi attivi jew għal xi wieħed mis-sustanzi mhux attivi jew neomycin u polymyxin.

the active substance in colobreathe, colistimethate sodium, is an antibiotic from the polymyxin group.
is-sustanza attiva f’colobreathe, colistimethate sodium, hija antibijotiku tal-grupp ta’ polymyxin.

the vaccine may contain traces of glutaraldehyde, formaldehyde, neomycin, streptomycin and polymyxin b.
il-vaċċin jista 'jkun fiha traċċi ta' glutaraldehyde formaldehyde, neomycin, streptomycin u polymyxin b

hypersensitivity to the active substances or to any of the excipients listed in section 6.1, or formaldehyde, neomycin and polymyxin.
sensittività eċċessiva għas-sustanzi attivi jew għal kwalunkwe wieħed mill-eċċipjenti elenkati fis- sezzjoni 6.1, jew formalina, neomycin u polymyxin.

colobreathe must not be used in people who are hypersensitive (allergic) to colistimethate sodium or to colistin sulphate or polymyxin b.
colobreathe ma għandux jintuża f’persuni li jistgħu jkunu ipersensittivi (allerġiċi) għal colistimethate sodium jew għal colistin sulphate jew għal polymyxin b.

since the mechanism of action of the polymyxins is different from that of other antibacterial agents, resistance to colistin and polymyxin by the above mechanism alone would not be expected to result in resistance to other drug classes.
peress li l-mekkaniżmu ta’ azzjoni tal-polymyxins huwa differenti minn dak ta’ sustanzi antibatteriċi oħra, reżistenza għal colistin u polymyxin mill-mekkaniżmu t’hawn fuq biss ma tkunx mistennija li tirriżulta f’reżistenza għal klassijiet ta’ mediċina oħra.

colistimethate sodium (cms) is a cyclic polypeptide antibacterial active substance that is derived from bacillus polymyxa var. colistinus and belongs to the polymyxin group.
colistimethate sodium (cms) huwa sustanza attiva antibatterika li tikkonsisti minn polypetide ċikliku li ġej minn bacillus polymyxa var. colistinus u jappartjeni għal grupp ta’ polymyxin.

antibiotics (per ml final) must be added to the transport medium such as penicillin1000 iu, neomycin sulphate100 iu, polymyxin b sulphate50 iu, mycostatin100 iu.
antibijotiċi (għal kull ml finali) għandhom jiżdiedu mal-mezz tat-trasport bħal penicillin1000 iu, neomycin sulphate100 iu, polymyxin b sulphate50 iu, mycostatin100 iu.

the vaccine may contain traces of glutaraldehyde, formaldehyde, neomycin, streptomycin and polymyxin b which are used during the manufacturing process (see section 4.3).
il-vaċċin jista’ jkun fih traċċi ta’, glutaraldehyde, formaldehyde, neomycin, streptomycin u polymyxin b li jintużaw waqt il-proċess ta’ produzzjoni (ara sezzjoni 4.3).

polymyxins
polimiksini